ClinicalTrials.Veeva

Menu

Lifestyle Modification in the Treatment of NAFLD.

G

General University Hospital, Prague

Status

Enrolling

Conditions

NAFLD

Treatments

Behavioral: Cognitive behavioral therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05816915
NU23-01-00288

Details and patient eligibility

About

The project will study the impact of individually tailored lifestyle counselling compared to standard care on the parameters of NAFLD/NASH in patients with metabolic syndrome. The factors affecting the outcome (including clinical and laboratory parameters and microbiome profiling) will be evaluated.

Full description

Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of a metabolic syndrome, is a leading cause of chronic liver disease worldwide. NAFLD is associated with type 2 diabetes, obesity and genetic factors. Despite intensive effort and numerous trials, as of today there is no approved treatment for NAFLD. Weight reduction is recommended, but no long-term control study assessing the evolution of NAFLD/NASH (non-alcoholic steatohepatitis) during lifestyle modification is available.

The main objective of presented project is to compare the progression of NAFLD/NASH in patients with metabolic syndrome randomly assigned to a standard care or a professional lifestyle modification counselling during a 1-yr follow-up. The investigators hypothesize that professionally tailored life-style counselling in patient with metabolic syndrome and NAFLD will improve liver fat content and other non-invasive parameters of liver disease, and factors (including gut microbiota) affecting progression/regression of NAFLD will be identified.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Individuals with NAFLD and metabolic syndrome

Exclusion criteria

  • Etiology of liver disease other than NAFLD.
  • Presence of malignant disease.
  • Uncontrolled cardiovascular disease
  • Pregnancy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Professional lifestyle modification counselling (behavioral therapy)
Experimental group
Description:
Lifestyle intervention will be based on CBT (cognitive behavioral therapy) and mindfulness, especially mindful eating by professional organisation STOB.
Treatment:
Behavioral: Cognitive behavioral therapy
standard care
No Intervention group
Description:
Patients will have standard care with regular visits at an outpatient Department of Hepatology. Standard recommendations of lifestyle change and weight reduction will be given by hepatologists.

Trial contacts and locations

1

Loading...

Central trial contact

Radan Bruha, Prof.; Vaclav Smid, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems